These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 31886259)

  • 1. Application of Computational Biology and Artificial Intelligence Technologies in Cancer Precision Drug Discovery.
    Nagarajan N; Yapp EKY; Le NQK; Kamaraj B; Al-Subaie AM; Yeh HY
    Biomed Res Int; 2019; 2019():8427042. PubMed ID: 31886259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Artificial Intelligence in Discovery and Development of Anticancer and Antidiabetic Therapeutic Agents.
    Alqahtani A
    Evid Based Complement Alternat Med; 2022; 2022():6201067. PubMed ID: 35509623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutting-Edge AI Technologies Meet Precision Medicine to Improve Cancer Care.
    Lin PC; Tsai YS; Yeh YM; Shen MR
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Artificial Intelligence-Powered New Era in Pharmaceutical Research and Development: A Review.
    Suriyaamporn P; Pamornpathomkul B; Patrojanasophon P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    AAPS PharmSciTech; 2024 Aug; 25(6):188. PubMed ID: 39147952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence for Precision Oncology.
    Bhalla S; Laganà A
    Adv Exp Med Biol; 2022; 1361():249-268. PubMed ID: 35230693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Artificial Intelligence in Drug Discovery.
    Chopra H; Baig AA; Gautam RK; Kamal MA
    Curr Pharm Des; 2022; 28(33):2690-2703. PubMed ID: 35676841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular-based precision oncology clinical decision making augmented by artificial intelligence.
    Zeng J; Shufean MA
    Emerg Top Life Sci; 2021 Dec; 5(6):757-764. PubMed ID: 34874054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on Deep Learning-driven Drug Discovery: Strategies, Tools and Applications.
    Sumathi S; Suganya K; Swathi K; Sudha B; Poornima A; Varghese CA; Aswathy R
    Curr Pharm Des; 2023 May; 29(13):1013-1025. PubMed ID: 37055908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine.
    Adir O; Poley M; Chen G; Froim S; Krinsky N; Shklover J; Shainsky-Roitman J; Lammers T; Schroeder A
    Adv Mater; 2020 Apr; 32(13):e1901989. PubMed ID: 31286573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging roles of artificial intelligence in cancer drug development and precision therapy.
    Liang G; Fan W; Luo H; Zhu X
    Biomed Pharmacother; 2020 Aug; 128():110255. PubMed ID: 32446113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial intelligence in early drug discovery enabling precision medicine.
    Boniolo F; Dorigatti E; Ohnmacht AJ; Saur D; Schubert B; Menden MP
    Expert Opin Drug Discov; 2021 Sep; 16(9):991-1007. PubMed ID: 34075855
    [No Abstract]   [Full Text] [Related]  

  • 13. Artificial intelligence for assisting cancer diagnosis and treatment in the era of precision medicine.
    Chen ZH; Lin L; Wu CF; Li CF; Xu RH; Sun Y
    Cancer Commun (Lond); 2021 Nov; 41(11):1100-1115. PubMed ID: 34613667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Artificial intelligence, physiological genomics, and precision medicine.
    Williams AM; Liu Y; Regner KR; Jotterand F; Liu P; Liang M
    Physiol Genomics; 2018 Apr; 50(4):237-243. PubMed ID: 29373082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tribulations and future opportunities for artificial intelligence in precision medicine.
    Carini C; Seyhan AA
    J Transl Med; 2024 Apr; 22(1):411. PubMed ID: 38702711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence and neoantigens: paving the path for precision cancer immunotherapy.
    Bulashevska A; Nacsa Z; Lang F; Braun M; Machyna M; Diken M; Childs L; König R
    Front Immunol; 2024; 15():1394003. PubMed ID: 38868767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opportunities and challenges in application of artificial intelligence in pharmacology.
    Kumar M; Nguyen TPN; Kaur J; Singh TG; Soni D; Singh R; Kumar P
    Pharmacol Rep; 2023 Feb; 75(1):3-18. PubMed ID: 36624355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AI (Artificial Intelligence) and Hypertension Research.
    Mueller FB
    Curr Hypertens Rep; 2020 Aug; 22(9):70. PubMed ID: 32852654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence in cancer target identification and drug discovery.
    You Y; Lai X; Pan Y; Zheng H; Vera J; Liu S; Deng S; Zhang L
    Signal Transduct Target Ther; 2022 May; 7(1):156. PubMed ID: 35538061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.